PD-1/PD-L and autoimmunity: A growing relationship.

Area of Science:

• Immunology
• Genetics
• Autoimmunity

Background:

• Programmed death 1 (PD-1) and its ligands (PD-L1, PD-L2) are key regulators of inhibitory T cell signaling, essential for immune tolerance and homeostasis.
• Dysfunctional PD-1:PD-L interactions are implicated in the pathogenesis of a wide spectrum of autoimmune diseases, including Type 1 diabetes, rheumatoid arthritis, and systemic lupus erythematosus.

Purpose of the Study:

• To comprehensively review the role of the PD-1:PD-L pathway in various autoimmune diseases.
• To highlight genetic associations and risk factors related to PD-1 gene polymorphisms in autoimmune conditions.

Main Methods:

• Literature review of recent studies on PD-1:PD-L function in autoimmune diseases.
• Analysis of genetic investigations, including genome-wide association studies and single nucleotide polymorphisms (SNPs) in the PD-1 gene.

Main Results:

• Evidence links impaired PD-1:PD-L signaling to numerous autoimmune conditions.
• Genetic studies reveal associations between PD-1 gene variations and increased autoimmune disease risk in specific ethnic groups.

Conclusions:

• The PD-1:PD-L pathway is a significant factor in maintaining immune homeostasis and its disruption contributes to autoimmunity.
• Genetic predisposition, particularly involving PD-1 gene polymorphisms, plays a role in the susceptibility to developing autoimmune diseases.